The average and median pain scores demonstrated a decreasing trend with increasing use time.
← all excerpts
Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment.
1
—
—
The average and median pain scores demonstrated a decreasing trend with increasing use time.